Top brokers name 3 ASX shares to buy next week 14 February 2021

Last week saw a number of broker notes hitting the wires once again. Three buy ratings that caught my eye are summarised below.

Here’s why brokers think investors ought to buy them next week:

According to a note out of the Macquarie equities desk, its analysts have retained their outperform rating and $241.00 price target on this hearing solutions company’s shares ahead of its half year results. While trading conditions are expected to have been tough, the broker appears optimistic that the second half will be stronger and Cochlear will grow ahead of the industry by winning market share from competitors. The Cochlear share price ended the week at $206.41.

A note out of UBS reveals that its analysts have retained their buy…